Browsing by Author Xianming Deng

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 10 of 10

Issue DateTitleAuthor(s)
2010-07Broad spectrum alkynyl inhibitors of T315I Bcr-Abl임상민; Xianming Deng; Jianming Zhang, et al
2016-10Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-delta/gamma Inhibitors심태보; Fleur M. Ferguson; Jing Ni, et al
2015-01Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)Li Tan; Tyzoon Nomanbhoy; Deepak Gurbani, et al
2010-10Expanding the Diversity of Allosteric Bcr-Abl InhibitorsXianming Deng; Barun Okram; Qiang Ding, et al
2009-10N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric InhibitorYongmun Choi; Markus A. Seeliger; Shoghag B. Panjarian, et al
2012-04Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine KinaseSabine Hellwig; Chandra V. Miduturu; Shigeru Kanda, et al
2018-09Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains심태보; Jinhua Wang; Tatiana Erazo, et al
2013-12Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesXianming Deng; Jonathan M. Elkins; Jinwei Zhang, et al
2012Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett; Elena J. Edelman; Sonja J. Heidorn, et al
2010-01Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJianming Zhang; Francisco J. Adrian; Wolfgang Jahnke, et al

BROWSE